New vaccine aims to shield moms and babies from dangerous strep b
NCT ID NCT06611371
Summary
This study is testing a new vaccine designed to protect healthy women of childbearing age from Group B Streptococcus (GBS) infections. GBS can cause serious illness in newborns. Researchers are giving about 600 women in the US and South Africa either the vaccine at one of three different strengths or a placebo shot to see how safe it is and if it triggers a good immune response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GROUP B STREPTOCOCCAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NYU Grossman School of Medicine
New York, New York, 10016, United States
-
Wits Vaccines and Infectious Diseases Analytics Research Unit (Wits-VIDA), University of the Witwatersrand
Johannesburg, Gauteng, South Africa
Conditions
Explore the condition pages connected to this study.